M I P I
Favorable prognosis with standard chemoimmunotherapy
Why This Health Metric Matters
Why: This calculation helps assess important health parameters for clinical and personal wellness tracking.
How: Enter your values above and the calculator will apply validated formulas to compute your results.
- ●Evidence-based calculations
- ●Used in clinical settings worldwide
- ●Regular monitoring recommended
Clinical Scenarios
MIPI Parameters (Required)
MIPI-c (Optional Ki-67)
Clinical Context
⚠️For educational and informational purposes only. Verify with a qualified professional.
🏥 Health Facts
— WHO
— CDC
What is the MIPI?
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is a validated prognostic scoring system developed specifically for MCL. It stratifies patients into three risk groups with distinct survival outcomes.
Low Risk
MIPI < 5.7
Median OS: Not reached (>5 years)
5-year OS: ~60%
Intermediate Risk
MIPI 5.7-6.2
Median OS: ~51 months
5-year OS: ~35%
High Risk
MIPI > 6.2
Median OS: ~29 months
5-year OS: ~20%